Updated:
Segulah Medical Acceleration
Segulah Medical Acceleration invests in and develops medical technology businesses, focusing on devices, diagnostics, and life science tools.
Segulah Medical Acceleration
Segulah Medical Acceleration invests in and develops medical technology businesses, focusing on devices, diagnostics, and life science tools. Based in Stockholm, Sweden, the company connects innovation with commercial validation. It has made 9 investments, including a Seed VC in Basic Genomics on April 25, 2025, and has a portfolio exit in Allurion on August 02, 2023.
General information
Firm type
Private Equity
Year founded
2021
AUM
SEK 1.3bn (~EUR 120m) (per firm website)
Location
Region
Europe
Country
Sweden
City
Stockholm
Corporate office
Riddargatan 13K, Box 5483, 114 84 Stockholm, Sweden
Principals
Susanna Francke Rodau
Team member (specific title not publicly listed on firm website)
Maria Tell
Team member (specific title not publicly listed on firm website)
Jan Andersson
Team member (specific title not publicly listed on firm website)
Karin Leire
Team member (specific title not publicly listed on firm website)
Ludvig Wendel
Team member (specific title not publicly listed on firm website)
Emanuel Sanne
Team member (specific title not publicly listed on firm website)
Lars Axelson
Team member (specific title not publicly listed on firm website)
Ulrika Wedén
Team member (specific title not publicly listed on firm website)
Åsa von Schoting
Team member (specific title not publicly listed on firm website)
Melissa Rutencrantz
Team member (specific title not publicly listed on firm website)
Veronika Johansson
Team member (specific title not publicly listed on firm website)
Claes Ekström
Team member (specific title not publicly listed on firm website)
Gabriel Urwitz
Team member (specific title not publicly listed on firm website)
Angelica Fatouros
Team member (specific title not publicly listed on firm website)
Mikael Kamras
Team member (specific title not publicly listed on firm website)
Britta Wallgren
Team member (specific title not publicly listed on firm website)
Hans Wigzell
Team member (specific title not publicly listed on firm website)
Mikael Dolsten
Team member (specific title not publicly listed on firm website)
Jonas Frisén
Team member (specific title not publicly listed on firm website)
Kevin Tracy
Team member (specific title not publicly listed on firm website)
Klas Kärre
Team member (specific title not publicly listed on firm website)
Olle Kämpe
Team member (specific title not publicly listed on firm website)
Anna Blom
Team member (specific title not publicly listed on firm website)
Sector focus
Frequently asked questions
What is Segulah Medical Acceleration?
Segulah Medical Acceleration is a private equity headquartered in Stockholm, Sweden.
When was Segulah Medical Acceleration founded?
Segulah Medical Acceleration was founded in 2021.
Where is Segulah Medical Acceleration headquartered?
Segulah Medical Acceleration is headquartered in Stockholm, Sweden, in the Europe region.
What is Segulah Medical Acceleration's assets under management?
Segulah Medical Acceleration reports approximately SEK 1.3bn (~EUR 120m) (per firm website) in assets under management, as tracked by Altss.
What does Altss track for Segulah Medical Acceleration?
Altss maintains an OSINT-verified profile of Segulah Medical Acceleration covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), and network (associations and event participation). Detailed values are available to Altss subscribers.
What is Segulah Medical Acceleration's website?
Segulah Medical Acceleration's public website is www.segulahmedical.com. Verified contact details for principals and decision-makers are available to Altss subscribers.
What type of firm is Segulah Medical Acceleration?
Segulah Medical Acceleration is classified by Altss as a Private Equity, operating from Sweden within the Europe region.
How does Altss source intelligence on Segulah Medical Acceleration?
Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.
When was Segulah Medical Acceleration's Altss profile last updated?
Segulah Medical Acceleration's profile on Altss was last refreshed on June 3, 2026. Continuous updates are applied as new public information is verified.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: